Case report. Use of an argon laser to treat drug-induced gingival overgrowth.
This article explores the use of an argon laser to treat severe drug-induced gingival overgrowth. The patient was being treated with phenytoin (Dilantin, Parke-Davis), cyclosporine and a calcium channel blocker. He had undergone a kidney transplantation and had insulin-dependent diabetes mellitus. He had severe gingival overgrowth, which prevented him from wearing his removable prostheses, and a superimposed Candida albicans infection. An argon laser was used to excise the gingival overgrowth so new maxillary and mandibular prostheses could be fabricated.
Mattson
J S
JS
Department of Periodontics, Creighton University School of Dentistry, Omaha, Neb. 68178, USA.
Blankenau
R
R
Keene
J J
JJ
D000927:Anticonvulsants / Q000009:adverse effects*; D001128:Argon; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002180:Candidiasis, Oral / Q000150:complications; D016572:Cyclosporine / Q000009:adverse effects*; D003824:Denture, Complete; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005885:Gingival Hyperplasia / Q000139:chemically induced / Q000601:surgery*; D005890:Gingivectomy / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation; D053685:Laser Therapy / Q000379:methods; D008297:Male; D008875:Middle Aged; D010353:Patient Education as Topic; D010672:Phenytoin / Q000009:adverse effects*
D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D010672:Phenytoin; D001128:Argon; D016572:Cyclosporine